The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Linezolid Shortage: What Providers and Prescribers Need to Know in 2026
The linezolid IV shortage impacts inpatient and discharge planning in 2026. Here's what prescribers and clinical teams need to know about alternatives, stewardship, and supply navigation.
Methocarbamol Shortage: What Providers and Prescribers Need to Know in 2026
Clinical briefing for providers: Methocarbamol availability in 2026, prescribing implications, therapeutic alternatives, and tools to help patients access their medication.
Nepafenac Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Nepafenac (Nevanac, Ilevro) availability, supply chain status, and practical alternatives for ophthalmologists and prescribers in 2026.
Pylera Shortage: What Providers and Prescribers Need to Know in 2026
Pylera isn't on the FDA shortage list, but your patients may still struggle to find it. Here's what's driving access issues in 2026 and how to support your patients.
40,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Spritam Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for neurologists and prescribers on Spritam availability in 2026 — supply context, prescribing strategies, and patient support resources.
Sulfamethoxazole/Trimethoprim Shortage: What Providers and Prescribers Need to Know in 2026
A 2026 clinical guide for prescribers managing sulfamethoxazole/trimethoprim availability gaps, including therapeutic substitution and patient counseling strategies.
Topamax Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on topiramate availability in 2026 for neurologists, PCPs, and other prescribers. Covers supply status, formulary considerations, and patient guidance.
Yupelri Availability: What Providers and Prescribers Need to Know in 2026
Yupelri (revefenacin) presents unique access challenges for prescribers. Here's the 2026 clinical guidance on availability, formulary barriers, and patient support strategies.
Mesalamine XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Mesalamine XR availability in 2026: ASHP shortage status, prescribing implications, alternative formulations, and patient access tools.
Dorzolamide Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for ophthalmologists, optometrists, and prescribers on dorzolamide availability in 2026, including patient counseling tips, therapeutic alternatives, and formulary considerations.
How to Help Your Patients Save Money on Feirza 1/20: A Provider's Guide to Savings Programs
A provider's guide to helping patients reduce out-of-pocket costs for Feirza 1/20 in 2026 — ACA coverage mandates, discount programs, Medicaid, and prescribing strategies.
How to Help Your Patients Save Money on Mycophenolic Acid: A Provider's Guide to Savings Programs
A provider's guide to mycophenolic acid savings programs: co-pay cards, patient assistance, Medicare coverage, and how to help transplant patients afford lifelong immunosuppression.